Health approves administering the Janssen vaccine to people aged 40 to 49 years
The Public Health Commission, which brings together the directors of Public Health of the Ministry of Health and the communities, has approved this Tuesday the use of the Janssen / Johnson & Johnson vaccine against COVID-19 for the age group 40 to 49 years. They will be immunized "once the vaccination of those over 50 years of age has been completed", with this drug and also with the two developed with messenger RNA, these are, that of Pfizer / BioNTech and that of Moderna.
